Passage Bio Inc
(PASG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | ||
| Net Income | -21,095 | -7,669 |
| Depreciation Amortization | 48 | 12 |
| Accounts payable and accrued liabilities | -104 | -47 |
| Other Working Capital | -392 | 3,286 |
| Other Operating Activity | 10,549 | 4,204 |
| Operating Cash Flow | $-10,994 | $-214 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1,041 | -884 |
| Purchase Sale Intangibles | -500 | N/A |
| Other Investing Activity | -500 | 0 |
| Investing Cash Flow | $-1,541 | $-884 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 176 | 176 |
| Other Financing Activity | 66,287 | 19,981 |
| Financing Cash Flow | $66,463 | $20,157 |
| Beginning Cash Position | 24,861 | 24,861 |
| End Cash Position | 78,789 | 43,920 |
| Net Cash Flow | $53,928 | $19,059 |
| Free Cash Flow | ||
| Operating Cash Flow | -10,994 | -214 |
| Capital Expenditure | -1,041 | -884 |
| Free Cash Flow | -12,035 | -1,098 |